The PCE price index faces a projected 0.4% spike as Q4 2025 GDP growth slows to 3%. Read why disruption risks are very high ...
Q4 2026 earnings preview: hold rating as growth normalizes, guidance implies 21% YoY; weigh risks & upside catalysts. Read ...
Procore Technologies, Inc. (NYSE:PCOR) Q4 2025 Earnings Call Transcript February 12, 2026 Procore Technologies, Inc. beats ...
Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) Q4 2025 Earnings Call Transcript February 12, 2026 Ultragenyx Pharmaceutical Inc. misses on earnings expectations. Reported EPS is $-1.29 EPS, expectations ...
Fiscal Q4 2025 Investments (period ended Dec. 31, 2025) -- $562 million completed, including the first SHOP deal with three Texas communities totaling 270 assisted living and memory care units.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results